| Literature DB >> 30857204 |
Marcelo D Catarino1, Artur M S Silva2, Nuno Mateus3, Susana M Cardoso4.
Abstract
Phlorotannins are phloroglucinol-based phenolic compounds, occurring particularly in brown macroalgae, that have been recognized for their promising bioactive properties. In this study, the extraction of phlorotannins from Fucus vesiculosus was evaluated with particular emphasis on the influential parameters, including the solvent concentration, solvent-solid ratio, extraction temperature and extraction time, using a single-factor design followed by a Box-Behnken design. The maximum total phlorotannin content, determined using the 2,4-dimethoxybenzaldehyde (DMBA) method, corresponded to 2.92 ± 0.05 mg of phloroglucinol equivalents/g dry seaweed (mg PGE/g DS), and was achieved for extracts carried out with acetone 67% (v/v), a solvent-solid ratio of 70 mL/g and temperature at 25 °C. This crude extract, together with a semi-purified phlorotannin fraction, were further evaluated for their anti-enzymatic capacity against α-glucosidase, α-amylase and pancreatic lipase, both showing promising inhibitory effects, particularly against α-glucosidase for which a greater inhibitory effect was observed compared to the pharmaceutical drug acarbose (IC50 = 4.5 ± 0.8 and 0.82 ± 0.3 μg/mL, respectively, against 206.6 ± 25.1 μg/mL). Additionally, the ultra-high-pressure liquid chromatography coupled to mass spectrometry (UHPLC-MS) analysis carried out on the ethyl acetate fraction revealed the presence of fucols, fucophlorethols, fuhalols and several other phlorotannin derivatives. Moreover, possible new phlorotannin compounds, including fucofurodiphlorethol, fucofurotriphlorethol and fucofuropentaphlorethol, have been tentatively identified in this extract. Overall, this study provides evidence that F. vesiculosus phlorotannin-rich extracts hold potential for the management of the activity of α-glucosidase, α-amylase and pancreatic lipase, which are well known to be linked to metabolic disorders such as diabetes and obesity.Entities:
Keywords: Fucus vesiculosus; diabetes; obesity; pancreatic lipase; phlorotannins; response surface methodology; α-amylase; α-glucosidase
Mesh:
Substances:
Year: 2019 PMID: 30857204 PMCID: PMC6471631 DOI: 10.3390/md17030162
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Figure 1Effect of (A) acetone concentration, (B) solvent-solid ratio, (C) temperature and (D) extracting time on the total phlorotannin content of F. vesiculosus extracts in the single-factor experiments. Initial extraction conditions consisted of 70% acetone, in a proportion of 1:20 (m:v) at room temperature during 24 h. Before moving to the next experiment, the previous condition was fixed at the point that showed the best total phlorotannin content (TPhC). Data represent the mean ± SEM of at least 3 independent assays and the results are expressed in mg of phloroglucinol equivalents/g of dried seaweed. Different letters represent statistical significance (one-way ANOVA followed by Tukey’s post hoc test; p ≤ 0.05).
Regression coefficients and results of ANOVA analysis of the model.
| Parameter | Regression Coefficient |
|---|---|
|
| 2.69 *** |
|
| 0.31 *** |
|
| 0.08 ** |
|
| 0.02 |
|
| −0.25 *** |
|
| 0.02 |
|
| −0.07 |
|
| 0.12 ** |
|
| −0.02 |
|
| 0.01 |
|
| 0.99 |
|
| 0.96 |
|
| 39.24 |
|
| <0.001 |
|
| 0.46 |
β0—constant coefficient; X1—acetone concentration (%); X2—solvent-solid ratio (mL/g); X3—extraction temperature (°C). **, *** represent statistical significance with p < 0.01 and 0.001, respectively.
Figure 2Response surface plots for the total phlorotannin content (TPhC in mg PGE/g DS) from F. vesiculosus extracts with respect to acetone concentration (%, X1) and solvent-solid ratio (mL/g, X2). The variable temperature was kept at its zero level.
Predicted and experimental values obtained for TPhC according to the predicted optimum conditions.
| Response | Optimum Conditions | Results | |||
|---|---|---|---|---|---|
|
|
|
| Predicted | Experimental | |
| TPhC (mg PGE/g DS) | 67 | 70 | 25 | 2.97 | 2.92 ± 0.05 |
X1—acetone concentration (%, v/v); X2—solvent-solid ratio (mL/g); X3—temperature (°C); TPhC—total phlorotannin content; PGE—phloroglucinol equivalents.
Extraction yield (as w/w of algal powder for crude extract and w/w of crude extract for the fractions) and total phlorotannin content of F. vesiculosus crude extract and further fractions.
| Sample | Yield (%) | TPhC (mg PGE/g ext) |
|---|---|---|
| Crude extract | 28.2 ± 2.1 | 10.7 ± 1.5 b |
| Hex | 15.5 ± 1.2 b | 4.0 ± 0. 9 c |
| EtOAc | 3.9 ± 0.6 c | 17.1 ± 1.5 a |
| AQ | 82.2 ± 2.3 a | 3.7 ± 0.5 c |
PGE—phloroglucinol equivalents; ext—extract; Hex—n-hexane fraction; EtOAc—ethyl acetate fraction; AQ—aqueous residue. Data expressed as mean ± standard deviation. Different letters within a column mean significantly differences at p < 0.05 using student’s t test.
Inhibition of α-glucosidase, α-amylase and lipase by F. vesiculosus crude extract, ethyl acetate fraction and the respective reference compounds.
| Sample | IC50 Value (μg/mL) | ||
|---|---|---|---|
| α-amylase | α-glucosidase | Pancreatic Lipase | |
| Crude extract | 28.8 ± 1.2 a | 4.5 ± 0.7 a | 45.9 ± 3.4 a |
| EtOAc | 2.8 ± 0.3 b | 0.82 ± 0.05 a | 19.0 ± 1.8 b |
| Acarbose | 0.7 ± 0.2 c | 206.6 ± 25.1 b | - |
| Orlistat * | - | - | 1.8 ± 0.5 c |
EtOAc—ethyl acetate fraction from F. vesiculosus extract. IC50 value was determined as the concentration at which α-amylase, α-glucosidase, and pancreatic lipase were inhibited by 50%. All values are expressed as mean ± SD. Different letters within a column mean significantly differences at p < 0.05 using student’s t test. * IC50 value for orlistat is expressed in ng/mL.
Figure 3Total ion chromatogram (TIC) of the EtOAc fraction. Peaks marked with numbers correspond to the tentatively identified compounds represented in Table 5.
Figure 4Structure of phlorotannin compounds tentatively identified in F. vesiculosus EtOAc fraction and proposed fragmentation patterns: (A) phloroglucinol ([M − H]− at m/z 125), (B) bifucol ([M − H]− at m/z 373), (C) trifucol ([M − H]− at m/z 497), (D) hexafucol ([M − H]− at m/z 745), (E) ([M − H]− at m/z 621), (F) trifucodiphlorethol ([M − H]− at m/z 869), (G) difucotriphlorethol ([M − H]− at m/z 869), (H) trifucotetraphlorethol ([M − H]− at m/z 993), (I) dibenzodioxine-1,3,6,8-tetraol ([M − H]− at m/z 247), (J) fucofurodiphlorethol ([M − H]− at m/z 479) ([M − H]− at m/z 603). Fragmentations with simultaneous loss of water are only representative. Cleavage of the OH group may occur at different sites.
Tentative assignment of the compounds present in the ethyl acetate fraction of F. vesiculosus extract analyzed by LC-ESI-MS/MS.
| Peak | RT (min) | [M − H]− ( | MS/MS Fragments (-loss) * | Tentative Assignment |
|---|---|---|---|---|
| 1 | 1.8 | 373 | MS2[373]: | Trifucol |
| 2 | 1.9 | 497 | MS2[497]: | Tetrafucol |
| 529 | MS2[529]: | Hydroxytetrafuhalol | ||
| 689 | MS2[689]: | Phlorotannin derivative | ||
| 3 | 2.8 | 621 | MS2[621]: | Trifucophlorethol |
| 247 | MS2[247]: | Dibenzodioxine-1,3,6,8-tetraol | ||
| 4 | 3.1 | 555 | MS2[555]: | Phlorotannin derivative |
| 5 | 4.2 | 745 | MS2[745]: | Hexafucol |
| 6 | 5.2 | 623 | MS2[623]: | Phlorotannin derivative |
| 869 | MS2[869]: | Trifucotriphlorethol | ||
| 7 | 5.8 | 869 | MS2[869]: | Difucotetraphlorethol |
| 479 | MS2[479]: | Fucofurodiphlorethol | ||
| 8 | 6.2 | 479 | MS2[479]: | Fucofurodiphlorethol |
| 9 | 7.5 | 993 | MS2[993]: | Pentafucodiphlorethol |
| 603 | MS2[603]: | Fucofurotriphlorethol | ||
| 10 | 8.2 | 385 | MS2[385]: | Phlorotannin derivative |
| 993 | MS2[993]: | Hexafucophlorethol | ||
| 623 | MS2[623]: | Phlorotannin derivative | ||
| 11 | 10.0 | 363 | MS2[363]: | Phlorotannin derivative |
| 993 | MS2[993]: | Tetrafucotetraphloretol | ||
| 771 | MS2[771]: | Phlorotannin derivative | ||
| 12 | 10.2 | 361 | MS2[361]: | Phlorotannin derivative |
| 993 | MS2[993]: | Tetrafucotetraphloretol | ||
| 13 | 11.1 | 403 | MS2[403]: | Phlorotannin derivative |
| 711 | MS2[711]: | Phlorotannin derivative | ||
| 637 | MS2[637]: | Pentafuhalol | ||
| 14 | 11.5 | 317 | MS2[317]: | Phlorotannin derivative |
| 526 | MS2[526]: | Unidentified | ||
| 851 | MS2[851]: | Fucofuropentaphlorethol | ||
| 15 | 11.7 | 637 | MS2[637]: | Pentafuhalol |
| 16 | 12.2 | 610 | MS2[610]: | Unidentified |
| 317 | MS2[317]: | Phlorotannin derivative | ||
| 711 | MS2[711]: | Phlorotannin derivative | ||
| 899 | MS2[899]: | Phlorotannin derivative | ||
| 17 | 12.5 | 527 | MS2[527]: | Phlorotannin derivative |
| 635 | MS2[635]: | Phlorotannin derivative | ||
| 719 | MS2[719]: | Phlorotannin derivative | ||
| 18 | 13.0 | 723 | MS2[723]: | Unidentified |
| 587 | MS2[587]: | Unidentified | ||
| 19 | 13.7 | 837 | MS2[837]: | Unidentified |
| 20 | 14.4 | 950 | MS2[950]: | Unidentified |
| 667 | MS2[667]: | Unidentified | ||
| 21 | 14.6 | 587 | MS2[587]: | Unidentified |
* Fragments are arranged in descending order of relative abundance with bold values highlighting the most abundant fragment.
Independent variables and their coded levels used in the BBD.
| Symbols | Independent Variables | Levels | ||
|---|---|---|---|---|
| −1 | 0 | 1 | ||
|
| Solvent concentration (% v/v) | 30 | 50 | 70 |
|
| Solvent-solid ratio (mL/g) | 30 | 50 | 70 |
|
| Temperature (°C) | 15 | 25 | 35 |
Box-Behnken experimental design matrix and the experimental and predicted values observed for TPhC.
| Extract No. | Independent Variables | TPhC (mg PGE/g DS) | |||
|---|---|---|---|---|---|
|
|
|
| Experimental | Predicted | |
| 1 | 30 | 30 | 25 | 2.21 | 2.19 |
| 2 | 30 | 70 | 25 | 2.13 | 2.12 |
| 3 | 70 | 30 | 25 | 2.55 | 2.56 |
| 4 | 70 | 70 | 25 | 2.94 | 2.97 |
| 5 | 50 | 30 | 15 | 2.56 | 2.54 |
| 6 | 50 | 30 | 35 | 2.53 | 2.57 |
| 7 | 50 | 70 | 15 | 2.73 | 2.69 |
| 8 | 50 | 70 | 35 | 2.72 | 2.74 |
| 9 | 30 | 50 | 15 | 1.98 | 2.03 |
| 10 | 70 | 50 | 15 | 2.67 | 2.68 |
| 11 | 30 | 50 | 35 | 2.12 | 2.11 |
| 12 | 70 | 50 | 35 | 2.73 | 2.68 |
| 13 | 50 | 50 | 25 | 2.63 | 2.69 |
| 14 | 50 | 50 | 25 | 2.70 | 2.69 |
| 15 | 50 | 50 | 25 | 2.73 | 2.69 |